Immunotherapy still the hot topic at cancer conference - Houston Chronicle

Houston Chronicle

Immunotherapy still the hot topic at cancer conference Houston Chronicle CHICAGO - The hottest advance in cancer treatment in 50 years began changing Chris Bolton's life a year ago. Bolton had come to Houston's M.D. Anderson Cancer Center for an experimental trial testing whether a new immunotherapy - the drug nivolumab ... Nivolumab demonstrates encouraging activity in metastatic colorectal cancerHealio Nivolumab immunotherapy helps patients with advanced bladder cancerMedical Xpress Nivolumab ± Ipilimumab Demonstrates Encouraging Activity, Survival in mCRCCancer Therapy Advisor Irish Independent -Irish Times -AJMC.com Managed Markets Network all 9 news articles »

from Health - Google News http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNEmKiN62RlmlEWp3SXyJ7EBsfQLLA&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52779127862456&ei=nCRVV7DMC8q13gGg-ojIBw&url=http://www.houstonchronicle.com/news/medical/article/Immunotherapy-still-the-hot-topic-at-cancer-7964829.php
via IFTTT